Santanu Maji

677 total citations
19 papers, 492 citations indexed

About

Santanu Maji is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Santanu Maji has authored 19 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Santanu Maji's work include Hippo pathway signaling and YAP/TAZ (5 papers), Axon Guidance and Neuronal Signaling (5 papers) and Virus-based gene therapy research (4 papers). Santanu Maji is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (5 papers), Axon Guidance and Neuronal Signaling (5 papers) and Virus-based gene therapy research (4 papers). Santanu Maji collaborates with scholars based in United States, India and Norway. Santanu Maji's co-authors include Paul B. Fisher, Swadesh K. Das, Luni Emdad, Rupesh Dash, Sabindra K. Samal, Maurizio Pellecchia, Rachna Rath, Omprakash Shriwas, Devanand Sarkar and Anjan K. Pradhan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Santanu Maji

19 papers receiving 487 citations

Peers

Santanu Maji

ONCOL

IMMUN

Xin‐Zhe Li China

Hengxing Chen China

Fang Sui China

Arijit Bhowmik India

Xiaoxiao Wang United States

Vanessa Morales-Tirado United States

Alia Ghoneum United States

Yuheng Yan China

Zonghui Ding United States

Xin‐Zhe Li China

Santanu Maji

356 ×1.2

95 ×0.6

ONCOL

95 ×0.9

53 ×0.6

IMMUN

37 ×0.7

Citations per year, relative to Santanu Maji Santanu Maji (= 1×) peers Xin‐Zhe Li

Countries citing papers authored by Santanu Maji

Since Specialization

Citations

This map shows the geographic impact of Santanu Maji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santanu Maji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santanu Maji more than expected).

Fields of papers citing papers by Santanu Maji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Santanu Maji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santanu Maji. The network helps show where Santanu Maji may publish in the future.

Co-authorship network of co-authors of Santanu Maji

This figure shows the co-authorship network connecting the top 25 collaborators of Santanu Maji. A scholar is included among the top collaborators of Santanu Maji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Santanu Maji. Santanu Maji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Maji, Santanu, Amit Kumar, Luni Emdad, Paul B. Fisher, & Swadesh K. Das. (2024). Molecular landscape of prostate cancer bone metastasis. Advances in cancer research. 161. 321–365. 2 indexed citations

Bhoopathi, Praveen, Padmanabhan Mannangatti, Anjan K. Pradhan, et al.. (2024). Noninvasive therapy of brain cancer using a unique systemic delivery methodology with a cancer terminator virus. Journal of Cellular Physiology. 239(8). e31302–e31302. 3 indexed citations

Maji, Santanu, Amit Kumar, Praveen Bhoopathi, et al.. (2023). Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis. Molecular Cancer Therapeutics. 22(10). 1115–1127. 4 indexed citations

Bhoopathi, Praveen, Amit Kumar, Anjan K. Pradhan, et al.. (2023). Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity. Journal for ImmunoTherapy of Cancer. 11(11). e007624–e007624. 7 indexed citations

Pradhan, Anjan K., Praveen Bhoopathi, Santanu Maji, et al.. (2022). Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor. Frontiers in Oncology. 12. 812560–812560. 5 indexed citations

Bhoopathi, Praveen, Anjan K. Pradhan, Amit Kumar, et al.. (2022). Conversion of a Non-Cancer-Selective Promoter into a Cancer-Selective Promoter. Cancers. 14(6). 1497–1497. 1 indexed citations

Maji, Santanu, Sabindra K. Samal, Jiong Li, et al.. (2021). SARI inhibits growth and reduces survival of oral squamous cell carcinomas (OSCC) by inducing endoplasmic reticulum stress. Life Sciences. 287. 120141–120141. 7 indexed citations

Bhoopathi, Praveen, Anjan K. Pradhan, Santanu Maji, et al.. (2021). Theranostic Tripartite Cancer Terminator Virus for Cancer Therapy and Imaging. Cancers. 13(4). 857–857. 6 indexed citations

Pradhan, Anjan K., Amit Kumar, Sarmistha Talukdar, et al.. (2021). Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein. International Journal of Molecular Sciences. 23(1). 72–72. 11 indexed citations

10.

Pradhan, Anjan K., Santanu Maji, Praveen Bhoopathi, et al.. (2021). Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β. Proceedings of the National Academy of Sciences. 118(21). 26 indexed citations

11.

Das, Swadesh K., Santanu Maji, Praveen Bhoopathi, et al.. (2020). MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis. Pharmacological Research. 155. 104695–104695. 38 indexed citations

12.

Pradhan, Anjan K., Santanu Maji, Swadesh K. Das, et al.. (2020). MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein. Cancer and Metastasis Reviews. 39(3). 769–781. 32 indexed citations

13.

Rajesh, Y., Angana Biswas, Indranil Banerjee, et al.. (2020). Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma. Proceedings of the National Academy of Sciences. 117(22). 12324–12331. 38 indexed citations

14.

Das, Swadesh K., Timothy P. Kegelman, Anjan K. Pradhan, et al.. (2019). Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor. Molecular Cancer Therapeutics. 18(11). 1997–2007. 22 indexed citations

15.

Maji, Santanu, Omprakash Shriwas, Sabindra K. Samal, et al.. (2018). STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma. Carcinogenesis. 40(1). 173–183. 34 indexed citations

16.

Maji, Santanu, Sabindra K. Samal, Omprakash Shriwas, et al.. (2017). Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer. Advances in cancer research. 137. 37–75. 164 indexed citations

17.

Samantara, Aneeya K., Santanu Maji, Arnab Ghosh, et al.. (2016). Good's buffer derived highly emissive carbon quantum dots: excellent biocompatible anticancer drug carrier. Journal of Materials Chemistry B. 4(14). 2412–2420. 26 indexed citations

18.

Maji, Santanu, Sabindra K. Samal, Swagatika Panda, et al.. (2015). Mcl-1 is an important therapeutic target for oral squamous cell carcinomas. Oncotarget. 6(18). 16623–16637. 50 indexed citations

19.

Kumar, Amit, Ashutosh Kumar, Suchitra Mohanty, et al.. (2014). Kaposi Sarcoma Herpes Virus Latency Associated Nuclear Antigen Protein Release the G2/M Cell Cycle Blocks by Modulating ATM/ATR Mediated Checkpoint Pathway. PLoS ONE. 9(6). e100228–e100228. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact